General Disorders And Administration Site Conditions-injection site pain (0.6%). Hypersensitivity-rash (1.7%). Less frequently reported (<1%) were pruritus, fever or chills. Infections And Infestations-genital fungal infection (0.1%). Hematologic-eosinophilia (6%), thrombocytosis (5.1%) and leukopenia...
The incidence of warmth, tightness or induration was 17% (3/17) after IM administration of 350 mg/mL and 5% (1/20) after IM administration of 250 mg/mL. General Disorders And Administration Site Conditions - injection site pain (0.6%). Hypersensitivity - rash (1.7%). Less frequently ...
The incidence of warmth, tightness or induration was 17% (3/17) after IM administration of 350 mg/mL and 5% (1/20) after IM administration of 250 mg/mL. GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS—injection site pain (0.6%). HYPERSENSITIVITY—rash (1.7%). Less frequently ...
–all prepared solutions should be used as soon as possible and retain their efficacy for six hours at room temperature Intramuscular injection –dissolve 250mg or 500mg in 2ml, or 1g in 3.5ml, of lignocaine 1% solution –administer by deep intragluteal injection –no more than 1g should be...